Coagulation factor XIII (FXIII) is a transglutaminase which in the presence of Ca ++ and thrombin catalyses the formation of covalent bonds between c-glutamyl and -lysine residues of a-and c-fibrin chains, making fibrin stronger and insoluble [1]. In plasma, FXIII is a heterotetramer composed of four subunits (A2B2) of approximately 75 KD each, held together by non-covalent bonds. The catalytic function is expressed by the subunit A, while the subunit B functions as a carrier protein. In platelets, only the A subunits are present [1].Factor XIII deficiency is a very rare (1:2 000 000 inhabitants), often severe inherited bleeding disorder caused by the deficiency of FXIII in plasma. Typically, patients with severe FXIII deficiency suffer from life-long recurrent bleeding episodes, spontaneous abortions in females and high frequency of intracerebral bleeding [2].There are two types of FXIII deficiency: XIIIA deficiency, which is characterized by mutations in FXIIIA subunit gene and XIIIB deficiency, which is more rare and characterized by mutations in FXIIIB subunit gene. As a result, patients with XIIIA deficiency have no FXIIIA subunit detectable in plasma and may have also mild (usually around 40-50%) subunit B deficiency, while patients with severe XIIIB deficiency show an equivalent, marked reduction of FXIII subunit A and B [2].F13 A gene maps to chromosome 6 (p24-25) and spans over 160 Kb [1]. It consists of 15 exons encoding for a 731 amino acid mature protein composed of an activation peptide (residues 1-37) and four distinct domains: b-sandwich (residues 38-183), central core (residues 184-515), barrel 1 (residues 516-627) and barrel 2 regions (residues 628-731) [3]. The F13B gene is located on the long arm of chromosome 1 (q32-32.